FHIR IG Statistics: ValueSet/2.16.840.1.113762.1.4.1078.1033
| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | 2.16.840.1.113762.1.4.1078.1033 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1078.1033/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1033 |
| Version | 20250422 |
| Status | active |
| Date | 2025-04-22T01:09:50-04:00 |
| Name | SGLT2iAllergyNDFRT |
| Title | SGLT2i Allergy NDFRT |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: NDFRT codes for the drug class SGLT2i),(Data Element Scope: NDFRT codes representing the SGLT2i class),(Inclusion Criteria: Codes which are (1) Chemical/Ingredient (2) EPC, or (3) MoA),(Exclusion Criteria: N/A) |
Resources that use this resource
Resources that this resource uses
| CodeSystem |
| ndfrt | National Drug File Reference Terminology (NDF-RT) |
Narrative
No narrative content found in resource
Source
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1078.1033",
"meta": {
"versionId": "9",
"lastUpdated": "2025-04-22T01:09:50.000-04:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "Optum Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2025-04-22"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2025-04-22"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1033",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1078.1033"
}
],
"version": "20250422",
"name": "SGLT2iAllergyNDFRT",
"title": "SGLT2i Allergy NDFRT",
"status": "active",
"date": "2025-04-22T01:09:50-04:00",
"publisher": "Optum Steward",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: NDFRT codes for the drug class SGLT2i),(Data Element Scope: NDFRT codes representing the SGLT2i class),(Inclusion Criteria: Codes which are (1) Chemical/Ingredient (2) EPC, or (3) MoA),(Exclusion Criteria: N/A)",
"compose": {
"include": [
{
"system": "http://hl7.org/fhir/ndfrt",
"concept": [
{
"code": "N0000187058",
"display": "Sodium-Glucose Transporter 2 Inhibitors [MoA]"
},
{
"code": "N0000187059",
"display": "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"
},
{
"code": "N0000191980",
"display": "Canagliflozin [Chemical/Ingredient]"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:93274b91-0502-4c6f-9d97-b0c53e53adca",
"timestamp": "2025-05-23T17:44:50-04:00",
"total": 3,
"contains": [
{
"system": "http://hl7.org/fhir/ndfrt",
"version": "20180301",
"code": "N0000187058",
"display": "Sodium-Glucose Transporter 2 Inhibitors [MoA]"
},
{
"system": "http://hl7.org/fhir/ndfrt",
"version": "20180301",
"code": "N0000187059",
"display": "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"
},
{
"system": "http://hl7.org/fhir/ndfrt",
"version": "20180301",
"code": "N0000191980",
"display": "Canagliflozin [Chemical/Ingredient]"
}
]
}
}
FHIR